CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons
Open Access
- 15 October 2010
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 24 (20) , 2330-2342
Abstract
Serotonin is a bioamine regulating bone mass accrual differently depending on its site of synthesis. It decreases accrual when synthesized in the gut, and increases it when synthesized in the brain. The signal transduction events elicited by gut-derived serotonin once it binds to the Htr1b receptor present on osteoblasts have been identified and culminate in cAMP response element-binding protein (CREB) regulation of osteoblast proliferation. In contrast, we do not know how brain-derived serotonin favors bone mass accrual following its binding to the Htr2c receptor on neurons of the hypothalamic ventromedial nucleus (VMH). We show here—through gene expression analysis, serotonin treatment of wild-type andHtr2c−/−hypothalamic explants, and cell-specific gene deletion in the mouse—that, following its binding to the Htr2c receptor on VMH neurons, serotonin uses a calmodulin kinase (CaMK)-dependent signaling cascade involving CaMKKβ and CaMKIV to decrease the sympathetic tone and increase bone mass accrual. We further show that the transcriptional mediator of these events is CREB, whose phosphorylation on Ser 133 is increased by CaMKIV following serotonin treatment of hypothalamic explants. A microarray experiment identified two genes necessary for optimum sympathetic activity whose expression is regulated by CREB. These results provide a molecular understanding of how serotonin signals in hypothalamic neurons to regulate bone mass accrual and identify CREB as a critical determinant of this function, although through different mechanisms depending on the cell type, neuron, or osteoblast in which it is expressed.Keywords
This publication has 64 references indexed in Scilit:
- Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosisNature Medicine, 2010
- FoxO1 Is a Positive Regulator of Bone Formation by Favoring Protein Synthesis and Resistance to Oxidative Stress in OsteoblastsCell Metabolism, 2010
- A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy ExpenditureCell, 2009
- Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the DuodenumCell, 2008
- Synthesis, trafficking, and localization of muscarinic acetylcholine receptorsPharmacology & Therapeutics, 2008
- Ca2+/Calmodulin Kinase Kinase α Is Dispensable for Brain Development but Is Required for Distinct Memories in Male, though Not in Female, MiceMolecular and Cellular Biology, 2006
- ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiaeCell Metabolism, 2006
- AP-1 in mouse development and tumorigenesisOncogene, 2001
- Aplysia CREB2 represses long-term facilitation: Relief of repression converts transient facilitation into long-term functional and structural changeCell, 1995
- Induction of a dominant negative CREB transgene specifically blocks long-term memory in DrosophilaCell, 1994